Opinion | Israel’s Moral Balance Beam - The New York Times
2 days ago • Google News
Beam Therapeutics Inc (BEAM)
US$ 172.29%
Price Chart
Key Statistics
Market Cap
$ 2.13B
P/E Ratio
0.00
Revenue (TTM)
$ 63.58M
Volume
1.13M
52W High
$ 35.25
52W Low
$ 13.53
Dividend Yield
0.00%
Beta
2.08
Technicals
50-Day MA
17.8543
200-Day MA
22.975
52 Week High
35.25
52 Week Low
13.525
About BEAM
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.
Employees
393
Headquarters
Cambridge, MA
CEO
Mr. John M. Evans M.B.A.
Latest News
Karen Beam Obituary (2025) - Vandalia, OH - Dayton Daily News - Legacy.com
1 hour ago • Google News
Man dead after being pinned by steel beam on the job in Calhoun County - WBRC
5 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg